Two Sigma Advisers LP Boosts Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Two Sigma Advisers LP increased its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 1,301.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 189,200 shares of the company's stock after buying an additional 175,700 shares during the period. Two Sigma Advisers LP owned about 0.16% of Definitive Healthcare worth $778,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. SG Americas Securities LLC grew its position in shares of Definitive Healthcare by 44.6% in the 4th quarter. SG Americas Securities LLC now owns 27,189 shares of the company's stock valued at $112,000 after buying an additional 8,387 shares during the last quarter. Rhumbline Advisers raised its position in shares of Definitive Healthcare by 5.2% during the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company's stock worth $334,000 after acquiring an additional 4,034 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Definitive Healthcare by 9.7% in the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company's stock worth $181,000 after acquiring an additional 3,874 shares during the period. New York State Common Retirement Fund boosted its holdings in Definitive Healthcare by 3.2% in the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company's stock valued at $3,172,000 after acquiring an additional 23,815 shares during the last quarter. Finally, Ieq Capital LLC bought a new stake in Definitive Healthcare in the fourth quarter valued at approximately $51,000. 98.67% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on DH shares. BTIG Research downgraded shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. The Goldman Sachs Group increased their price objective on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. Barclays cut their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a research report on Monday, March 3rd. Finally, Wall Street Zen cut Definitive Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, May 31st. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $5.10.

Definitive Healthcare Stock Performance

NASDAQ DH traded up $0.06 during trading hours on Thursday, reaching $3.61. 337,409 shares of the company were exchanged, compared to its average volume of 811,238. The stock has a market capitalization of $535.85 million, a P/E ratio of -1.16, a P/E/G ratio of 4.06 and a beta of 1.58. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare Corp. has a 1 year low of $2.15 and a 1 year high of $6.27. The business's 50 day simple moving average is $2.89 and its 200-day simple moving average is $3.75.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.03. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company had revenue of $59.19 million for the quarter, compared to analysts' expectations of $56.20 million. During the same quarter in the previous year, the firm posted $0.08 EPS. Definitive Healthcare's revenue was down 6.8% on a year-over-year basis. On average, equities research analysts expect that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.